Inactive Instrument
Checkmate Pharmaceuticals, Inc. Stock
Stocks
CMPI
US1628181083
Biotechnology & Medical Research
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 62 | 12/12/2018 | |
Robert Landry
DFI | Director of Finance/CFO | 62 | 31/05/2022 |
James Wooldridge
CTO | Chief Tech/Sci/R&D Officer | 60 | 01/10/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Nouhad Husseini
BRD | Director/Board Member | - | 31/05/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 31/05/22 | Issuer sale | Chief Executive Officer | 279,437 | 1.2919% | ||
| 31/05/22 | Issuer sale | Director | 30,030 | 0.1388% | ||
| 31/05/22 | Issuer sale | Director | 20,061 | 0.0927% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | +0.38% | - | - | 231M | |
| -1.82% | +4.80% | +56.71% | +68.36% | 57.28B | |
| -0.27% | +0.35% | +40.26% | +79.88% | 54.99B | |
| -2.05% | -2.14% | +0.75% | +413.38% | 23.18B | |
| +1.97% | -1.16% | -21.00% | -13.25% | 22.59B | |
| -0.26% | -0.67% | +20.50% | -10.95% | 20.46B | |
| +1.57% | +3.30% | +28.01% | -29.07% | 17.56B | |
| -1.17% | -0.68% | +32.98% | +550.03% | 15.67B | |
| +5.29% | +1.70% | +185.09% | +333.94% | 14.46B | |
| +0.79% | +0.50% | +22.39% | +184.74% | 13.92B | |
| Average | +0.42% | +1.51% | +40.63% | +175.23% | 26.68B | |
| Weighted average by Cap. | -0.12% | +1.53% | +39.24% | +136.91% |
Employees
31
